Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BIOMARKERS FOR DRUG SELECTION IN DEPRESSION: 3BD Test

NCT07269886 is registered in ClinicalTrials.gov with Neomente SAS as lead sponsor.

NCT NCT07269886
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07269886 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BIOMARKERS FOR DRUG SELECTION IN DEPRESSION: 3BD Test
Lead sponsor
Neomente SAS
Phase
Observational
Overall status
Completed
Start date
August 18, 2022
Completion date
June 30, 2025
Enrollment
79 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression - major depressive disorder